Dehaier Medical Systems Ltd  

(Public, NASDAQ:DHRM)   Watch this stock  
Find more results for DHRM
1.91
+0.01 (0.53%)
May 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.90 - 1.92
52 week 1.47 - 2.99
Open 1.90
Vol / Avg. 0.00/13,117.00
Mkt cap 8.77M
P/E 3.20
Div/yield     -
EPS 0.60
Shares 4.59M
Beta 2.32
Inst. own 0%
Aug 9, 2013
Q2 2013 Dehaier Medical Systems Ltd Earnings Release Add to calendar
Mar 18, 2013
Q4 2012 Dehaier Medical Systems Ltd Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin 18.86% 14.44%
Operating margin 25.53% 16.69%
EBITD margin - 18.77%
Return on average assets 11.37% 8.70%
Return on average equity 13.32% 11.65%
Carbon Disclosure Rating - -

Address

No.45 Yongan Road Science Park, Changping District
BEIJING, BEJ 102200
China
+86-10-51660608 (Phone)
+86-10-89718090 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Dehaier Medical Systems Limited (Dehaier) designs, develops and markets its branded products in China. The Company imports the majority of the products and medical components it sells to its customers. The Company designs and develops some of the medical components that are part of the branded products to be distributed. Some of these medical components are manufactured by contractors in China because it does not have a manufacturing facility. Most of its branded products require light assembly. The Company focuses on the development and distribution of medical devices. In addition to Dehaier�s branded products, it also serves as a distributor of products designed and manufactured by other companies. The Company broadens product portfolio through distribution agreements with international manufacturers. In May 2012, the Company announced that it established a wholly owned United States subsidiary, BreathCare, LLC.

Officers and directors

Ping Chen Chairman of the Board, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Jingli Li Chief Financial Officer, Principal Financial and Accounting Officer, Director
Age: 27
Bio & Compensation  - Reuters
Yanying Qi Vice President
Age: 33
Bio & Compensation  - Reuters
Genhui Chen Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
Yunxiang Fan Independent Director
Age: 47
Bio & Compensation  - Reuters
Mingwei Zhang Independent Director
Age: 59
Bio & Compensation  - Reuters